MLPNX
Price
$7.79
Change
+$0.12 (+1.56%)
Updated
Jun 2 closing price
Net Assets
331.2M
SPMJX
Price
$7.09
Change
+$0.11 (+1.58%)
Updated
Jun 2 closing price
Net Assets
331.2M
Interact to see
Advertisement

MLPNX vs SPMJX

Header iconMLPNX vs SPMJX Comparison
Open Charts MLPNX vs SPMJXBanner chart's image
MLPNX vs SPMJX Comparison Chart in %
View a ticker or compare two or three
VS
MLPNX vs. SPMJX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPNX is a Buy and SPMJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPNX (331M) and SPMJX (331M) have equal amount of cash in the bank . SPMJX pays higher dividends than MLPNX: SPMJX (5.13) vs MLPNX (4.67). MLPNX was incepted earlier than SPMJX: MLPNX (14 years) vs SPMJX (7 years). SPMJX (3.99) is less costly to investors than MLPNX (3.49). MLPNX (25.00) and SPMJX (25.00) have comparable annual turnover. MLPNX (1000) and SPMJX (1000) have matching initial minimum investment requirements. MLPNX (27.60) and SPMJX (26.90) have marching annual gain over last year. MLPNX (228.23) and SPMJX (220.37) have equivalent 5 years return.
MLPNXSPMJXMLPNX / SPMJX
Total Expense Ratio3.493.9987%
Annual Report Gross Expense Ratio3.493.9987%
Fund Existence14 years7 years-
Gain YTD23.53723.137102%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets331M331M100%
Annual Yield % from dividends4.675.1391%
Returns for 1 year27.6026.90103%
Returns for 3 years126.01122.98102%
Returns for 5 years228.23220.37104%
Returns for 10 years151.44N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMG310.528.07
+2.67%
Affiliated Managers Group
EPAC33.160.23
+0.70%
Enerpac Tool Group Corp
HBANP16.50-0.10
-0.60%
Huntington Bancshares
MKTW17.14-0.12
-0.67%
MarketWise Inc
AVIR4.28-0.11
-2.40%
Atea Pharmaceuticals